Innovation Crossroads: Tech, Business, and Global Impact

Duke-NUS's latest medical class isn't just a record for women; it's a strategic shift. Former artists, engineers, and advocates are entering medicine.

As Innovative Eyewear preps for a key investor conference, it's betting on AI and brand power to challenge giants in the booming smart eyewear market.

TWFG just secured a $125M credit facility. It's not just about money; it's a strategic move to accelerate acquisitions and pioneer an AI-driven future for insurance.

With EPA enforcement at a decade high, EHS leaders are under pressure. Encamp's new 'cradle-to-grave' waste platform promises a digital shield. But can it deliver?

BLUETTI's new SORA 500 solar panel packs 500 watts into a foldable, camp-table-sized frame, signaling a major shift for the off-grid power market.

A landmark study proves the link between environmental action and financial performance is not direct, but flows through a powerful new channel: consumer sales.

PO Wealth Sharing Group claims 200,000 users and a global footprint. But beneath the surface of this fintech success story lies a troubling pattern.

After a rocky Q1, Ellington Credit Company's active strategy in the volatile CLO market paid off, delivering strong returns and a blueprint for resilience.

FinTech innovator Wrapbook launches 'WRAPPED,' a new series demystifying Hollywood's complex finances, starting with the crucial Section 181 tax incentive.

An $85,000 fine and a revoked licence for a mortgage broker is just the start. We explore how Ontario's regulator is tightening its grip on the industry.

EV leader Orange EV's new KCKCC scholarship is more than charity; it's a blueprint for building a green-collar workforce from the ground up.

Amid a selective biotech market, Rakovina Therapeutics' oversubscribed placement highlights investor belief in its AI-powered strategy for next-gen cancer drugs.

James Bourne's PRWeek 40 Under 40 win isn't just an award. It's a story of how strategic litigation comms became a firm's powerhouse.

A novel dual-action antibody shows remarkable durability in Phase 2 trials, offering a potential six-month dosing schedule for millions with chronic sinusitis.

How did a 2019 startup top $100M in revenue? Victory Home Remodeling's rapid rise reveals a powerful strategy: investing in people over profits.

PROLIM's new 400-person center in India's tech capital, backed by Siemens, showcases the future of industry with executable digital twins and agentic AI.

With a 7th Inc. 5000 nod, ActivTrak's success isn't just about growth; it’s a sign that the C-suite now demands a clear ROI on its AI investments.

Quebec's funding for Roche's Itovebi offers new hope for breast cancer patients, but its complex approval reveals a national struggle over drug costs and access.

With new executive talent and an integrated strategy, F.N.B. Corp is targeting the ultra-wealthy. Can it rival global banks and private family offices?

River AI, led by an xAI co-founder, has secured $1.1B to build an open AI stack, aiming to shift AI ownership from big labs to individual companies.